Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes
Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes have?
Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes has 198 citations in the OpenAlex counts ScholarIQ stores.
When was Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes published?
Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes has 2007 year in the ScholarIQ index.
What is the open-access status of Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes?
Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes?
The DOI for Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes is on the source record.
What is the PMID of Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes?
The PMID for Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes is on the source record.
What is the OpenAlex record for Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes?
The OpenAlex for Supplementation of Conventional Therapy With the Novel Grain Salba (<i>Salvia hispanica L</i>.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes is on the source record.